Skip to main content
. 2017 Nov 15;27(1):87–93. doi: 10.1007/s10068-017-0205-0

Fig. 3.

Fig. 3

Tyramine contents in cheonggukjang system added with nicotinic acid at several levels (in situ). (A) Bacillus subtilis KCTC3014 (starter strain) + Enterococcus faecium KCCM12118 (tyramine high producing strain), (B) A + nicotinic acid (B3, TDC inhibitor) 0.10%, (C) A + B3 0.15%, (D) A + B3 0.20%, (E) A + B3 0.25%, (F) A + B3 0.30%. Data are presented as mean ± SD (n = 4). *p < 0.05 compared with 48 h of control cheonggukjang